SARS-CoV-2 IgM/IgG Antibody

Tsanangudzo Pfupi:

Iyi kit yakagadzirirwa in vitro qualitative yekuona yeSARS-CoV-2 IgG antibody mumasampuli emunhu e serum / plasma, ropa re venous uye nemunwe weropa, kusanganisira SARS-CoV-2 IgG antibody muvanhu vane hutachiona uye vaccine-vakabaiwa.

Tumira email kwatiri

Product Detail

Product Tags

Product name

HWTS-RT090-SARS-CoV-2 IgM/IgG Antibody Detection Kit (Colloidal goridhe nzira)

Chitupa

Epidemiology

Coronavirus Chirwere 2019 (COVID-19), ipneumonia inokonzerwa nehutachiona hwekoronavirus inonzi Severe Acute Respiratory Syndrome Corona-Virus 2 (SARS-CoV-2).SARS-CoV-2 inoona coronavirus mu β genus uye munhu anowanzo batwa neSARS-CoV-2.Iwo makuru masosi ehutachiona ndivo vakasimbiswa COVID-19 varwere uye asymptomatic mutakuri weSARS-CoV-2.Zvichienderana neazvino epidemiological kuferefeta, iyo incubation nguva ndeye 1-14 mazuva, kazhinji 3-7 mazuva.Zvinonyanya kuratidza fivha, chikosoro chakaoma, uye kuneta.Nhamba shoma yevarwere inoperekedzwa nemhino yemhino, runny mhino, kurwadziwa kwehuro, myalgia uye manyoka.

Technical Parameters

Nzvimbo yechinangwa	SARS-CoV-2 IgM/IgG Antibody
Kuchengetedza tembiricha	4℃-30℃
Muenzaniso mhando	Serum yevanhu, plasma, venous ropa uye nemunwe ropa
Sherufu hupenyu	24 mwedzi
Zviridzwa zvebetsero	Hazvidiwi
Extra Consumables	Hazvidiwi
Nguva yekuonekwa	10-15 mins
Zvakananga	Iko hakuna kuyambuka-kuita nehutachiona, senge Human coronavirus SARSr-CoV, MERSr-CoV, HCoV-OC43, HCoV-229E, HCoV-HKU1, HCOV-NL63, H1N1, novel furuwenza A (H1N1) hutachiona hwefuruwenza (2009) , mwaka H1N1 furuwenza utachiona, H3N2, H5N1, H7N9, furuwenza B utachiona Yamagata, Victoria, kufema syncytial utachiona A uye B, parainfluenza utachiona mhando 1,2,3, Rhinovirus A, B, C, adenovirus rudzi 1,2,3, 4,5,7,55.